Description | InMed Pharmaceuticals is a global leader in the development, manufacturing and commercialization of rare cannabinoids. With its subsidiary BayMedica, InMed has unparalleled cannabinoid manufacturing capabilities to serve a spectrum of consumer markets, including pharmaceutical and health and wellness. |
h1 tags | Your page doesn't have H1 tags. |
h2 tags | Unparalleled rare cannabinoid expertise Latest News Investor Alerts INM-755 THCV Tetrahydrocanabivarin Novel Cannabinoid Analogs |
Site Speed | 0.56609797477722 |
Alexa Rank: |
0 |
Site's Traffic |
Host | Type | Class | TTL | Target |
inmedpharma.com | HINFO | IN | 3789 |